ATS 2020 Advance Program

1:30 Hands-On Breakout Session: Hypothesis-Testing 1:50 Real-Time Metagenomics J. Erb-Downward, PhD, Ann Arbor, MI 2:10 Studying the Host-Microbiome Interface L.N. Segal, MD, New York, NY 2:30 Longitudinal Microbiome Studies D. Bogaert, MD, PhD, Edinburgh, United Kingdom 2:50 Break 3:00 Hands-On Breakout Session: Data Visualization 3:20 Integrating Multiple “Omes” M.H. Badri, BS, New York, NY 3:40 Questions and Answers with Panel Discussion CLINICAL • TRANSLATIONAL POSTGRADUATE COURSE PG10 BRONCHIECTASIS AND PULMONARY NONTUBERCULOUS MYCOBACTERIA INFECTION 2020 Pre-registration and additional fees required. Continental breakfast and box lunch included. Attendance is limited. Member: $350 In-Training Member: $200 Non-Member: $425 In-Training Non-Member: $300 Assembly on Pulmonary Infections and Tuberculosis 8:00 a.m. - 4:00 p.m. Target Audience Pulmonologists, infectious diseases specialists; fellows in pulmonary medicine, fellows in infectious diseases, respiratory therapists, advanced practice nurses and internal medicine residents. Objectives At the conclusion of this session, the participant will be able to: • integrate new pulmonary nontuberculous mycobacteria guidelines into daily practice; • gain new findings about recent science that underlies pathophysiology of bronchiectasis and pulmonary nontuberculous mycobacteria infection; • foster an environment of collegiality while improving care for bronchiectasis patients by way of excellence in clinical management, development of clinical trials and scientific research. The course will begin with the epidemiology and evaluation for etiology with attention to identifying treatable causes. Updated pulmonary NTM treatment guidelines with a pro-con debate in pulmonary mycobacterium abscessus infection will be presented. A comprehensive approach to the management of bronchiectasis will be reviewed and include airway clearance strategies, the use of inhaled antibiotics, and the role of surgery in bronchiectasis and pNTM infection. Emerging data in genetics, immunology, inflammation, and the microbiome that are beginning to elucidate the pathophysiology of bronchiectasis and pNTM susceptibility will be highlighted. Real-world difficult cases will be presented and discussed with expert panelists. For lunch, faculty speakers will be assigned to dedicated tables to allow participants for continued interaction and questions. Difficult cases will be discussed at the end of the course and will be provided pre-meeting to the participants. Chairing: P.J. McShane, MD, Chicago, IL A. Basavaraj, MD, ATSF, New York, NY S.H. Kasperbauer, MD, ATSF, Denver, CO 8:00 Epidemiology and Evaluation of Bronchiectasis and Nontuberculous Mycobacteria R. Thomson, MBBS, PhD, Greenslopes, Australia 8:30 Airway Clearance Techniques in Bronchiectasis M. McIlwaine, PhD, Vancouver, Canada 9:00 Antimicrobial Management in Bronchiectasis A.E. O’Donnell, MD, Washington, DC 9:30 Surgery for the Patient with Bronchiectais and Pulmonary Nontuberculosis Infection J.S. Donington, MD, MSCR, Chicago, IL 10:00 Break 10:15 Nontuberculosis Mycobacteria: New Guidelines C.L. Daley, MD, Denver, CO 10:45 Mycobacterium Abscessus Taxonomy and Treatment B. Brown-Elliott, MS, MT(ASCP)SM, Tyler, TX ATS 2020 • Philadelphia, PA FRIDAY • MAY 15 11